Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. News
  4. >
  5. Exane BNP Paribas Begins Coverage of Synopsys with Underperform Rating and Sets Price Target at $425

Exane BNP Paribas Begins Coverage of Synopsys with Underperform Rating and Sets Price Target at $425

Written by Emily J. Thompson, Senior Investment Analyst
stocks logo
SNPS.O-5.09%
Source: Benzinga
Updated: Oct 02 2025
0mins
Intellectia AI SwingMax
Intellectia AI SwingMax
Source: Benzinga
  • Real-time Intelligence: Benzinga Pro offers the fastest news alerts to help traders stay informed and make winning trades in the stock market.

  • Exclusive Community: Joining Benzinga Pro connects users with over 10,000 serious traders and provides access to exclusive stories and insights from Benzinga reporters.

stocks logo
SNPS.O
$0.0000%Past 6 months
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
no data image
No Data
Powered By
Intellectia
Analyst Views on SNPS
Wall Street analysts forecast SNPS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNPS is 559.38 USD with a low forecast of 425.00 USD and a high forecast of 630.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
16 Analyst Rating
Wall Street analysts forecast SNPS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNPS is 559.38 USD with a low forecast of 425.00 USD and a high forecast of 630.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Buy
3 Hold
2 Sell
Moderate Buy
Current: 477.260
sliders
Low
425.00
Averages
559.38
High
630.00
Current: 477.260
sliders
Low
425.00
Averages
559.38
High
630.00
Needham
Buy
maintain
$550 -> $580
2025-12-11
New
Reason
Needham
Price Target
$550 -> $580
2025-12-11
New
maintain
Buy
Reason
Needham raised the firm's price target on Synopsys to $580 from $550 and keeps a Buy rating on the shares. The company issued the first FY26 outlook that is slightly below the Street in revenue but decently above consensus in earnings, the analyst tells investors in a research note. Investors had been expecting a rocky FY26 guide given the typical post-M&A integration risks, but that Synopsys is guiding largely in-line and slightly better than the Street is certainly a pleasant surprise, the firm added.
KeyBanc
Jason Celino
Overweight
maintain
$575 -> $600
2025-12-11
New
Reason
KeyBanc
Jason Celino
Price Target
$575 -> $600
2025-12-11
New
maintain
Overweight
Reason
KeyBanc analyst Jason Celino raised the firm's price target on Synopsys to $600 from $575 and keeps an Overweight rating on the shares. The firm notes Synopsys posted modestly better Q4 revenue and EPS, and solid backlog of $11.4B. More importantly, the initial FY26 EPS outlook is meaningfully better than expected, driven by accelerated debt pay-down and cost synergies. KeyBanc is encouraged by the better bottom-line outlook.
Piper Sandler
Overweight
to
NULL
downgrade
$630 -> $602
2025-12-11
New
Reason
Piper Sandler
Price Target
$630 -> $602
2025-12-11
New
downgrade
Overweight
to
NULL
Reason
Piper Sandler lowered the firm's price target on Synopsys to $602 from $630 and keeps an Overweight rating on the shares. The firm would argue that Synopsys largely achieved what was needed. That said, organic EDA growth and free cash flow margins are likely to be the main nagging items coming out of the quarter. The company was not precise in its EDA vs. IP growth assumptions, but Piper believes FY26 guidance points to high single digit overall organic growth and low-double digits organic EDA growth.
BofA
Neutral -> Buy
upgrade
$500 -> $560
2025-12-11
New
Reason
BofA
Price Target
$500 -> $560
2025-12-11
New
upgrade
Neutral -> Buy
Reason
BofA upgraded Synopsys to Buy from Neutral with a price target of $560, up from $500.
See All Ratings
Financial AI Agent
Financial AI Agent
About SNPS
Synopsys, Inc. is engaged in providing engineering solutions from silicon to systems, enabling customers to innovate artificial intelligence (AI)-powered products. It delivers silicon design, intellectual property (IP), simulation and analysis solutions, and design services. It supplies mission-critical electronic design automation (EDA) software that engineers use to design and test integrated circuits (ICs). Its Design Automation segment includes its advanced silicon design, verification products and services and system integration products. This segment also includes digital, custom and field programmable gate arrays, integrated circuit design software, verification software and hardware products, system integration products and services, and manufacturing software products. Its Design IP segment includes its interface, foundation, security, and embedded processor IP, IP subsystems, and IP implementation services that serve companies in the semiconductor and electronics industries.

About the author

Emily J. Thompson
Preview
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Top News

Fed Cuts Interest Rates Amid Economic Concerns

11 Dec 25
news image

SpaceX Targets $800 Billion Valuation in Secondary Sale

06 Dec 25
news image

U.S. Consumer Sentiment Slightly Improves in December

06 Dec 25
news image

U.S. Consumer Spending Slows in September

06 Dec 25
news image

Related Articles

SBC Medical Acquires 575,052 Shares of Waqoo at JPY 1,900 Each

12:31 PM
news image

SBC Medical Acquires Waqoo for Approximately JPY 1.09 Billion

12:13 PM
news image

Sigh Up to Get Intellectia Insights

arrow icon

What factors contributed to Synopsys' strong Q4 2025 earnings performance?

arrow icon

How did Synopsys' partnership with Nvidia impact its market performance?

arrow icon

Will Synopsys' revenue projections for fiscal 2026 surpass analyst expectations?

arrow icon

How might the class action lawsuit affect Synopsys' stock performance in 2026?

arrow icon

What are the implications of Synopsys' workforce reduction on its operating margins?

People Also Watch

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free